Cutaneous melanoma (CM) is a malignancy with increasing occurrence. Its microRNA repertoire has been defined in a number studies, leading to candidates for biological and clinical relevance: miR-200a/b/c, miR-203, miR-205, miR-204, miR-211, miR-23b and miR-26a/b. Our work was aimed to validate the role of these candidate miRNAs in melanoma, using additional patients cohorts and in vitro cultures. miR-26a, miR-204 and miR-211 were more expressed in normal melanocytes, while miR-23b, miR-200b/c, miR-203 and miR-205 in epidermis and keratinocytes. None of the keratinocyte-related miRNAs was associated with any known mutation or with clinical covariates in melanoma. On the other hand, the loss of miR-204 was enriched in melanomas with NRAS sole mutation (Fisher exact test, P = 0.001, Log Odds = 1.67), and less frequent than expected in those harbouring CDKN2A mutations (Fisher exact test, P = 0.001, Log Odds - 1.09). Additionally, miR-204 was associated with better prognosis in two independent melanoma cohorts and its exogenous expression led to growth impairment in melanoma cell lines. Thus, miR-204 represents a relevant mechanism in melanoma, with potential prognostic value and its loss seems to act in the CDKN2A pathway, in cooperation with NRAS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844115PMC
http://dx.doi.org/10.1186/s12943-018-0819-8DOI Listing

Publication Analysis

Top Keywords

loss mir-204
8
mir-203 mir-205
8
mir-204 mir-211
8
fisher exact
8
exact test
8
test p = 0001
8
p = 0001 log
8
melanoma
7
mir-204
5
mir-204 expression
4

Similar Publications

Background And Aims: Type 2 diabetes mellitus (T2DM) is usually complicated by cardiovascular diseases, hyperglycemia, and obesity, which worsen the outcome for the patient. Since recent evidence underlines the epigenetic role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the management of these comorbidities, this study compared the effects of these agents, namely liraglutide, semaglutide, dulaglutide, and exenatide, on miRNA regulation in the management of T2DM.

Results: GLP-1RAs modify the expression of miRNAs involved in endothelial function, sugar metabolism, and adipogenesis, including but not limited to miR-27b, miR-130a, and miR-210.

View Article and Find Full Text PDF

Cancer cachexia is a complex metabolic syndrome characterized by unintentional loss of skeletal muscle and body fat. This syndrome is frequently associated with different types of cancer and negatively affects the prognosis and outcome of these patients. It involves a dynamic interplay between tumor cells and adipose tissue, where tumor-derived extracellular vesicles (EVs) play a crucial role in mediating intercellular communication.

View Article and Find Full Text PDF
Article Synopsis
  • - This study explored how the molecule miR-204-5p affects the gene SIRT1, and how these factors contribute to deafness in C57BL/6 mice, particularly focusing on changes between young and older mice.
  • - Researchers used various methods like auditory tests and cell assays to analyze hearing function and inner ear cell behavior, finding that higher levels of miR-204-5p are linked to lower levels of SIRT1 in older mice, indicating a negative correlation.
  • - The findings suggest that increasing miR-204-5p leads to cell death and hearing loss through endoplasmic reticulum stress (ERS), and that inhibiting miR-204-5p or activating SIRT1
View Article and Find Full Text PDF

Effects of miR-204-5p modulation on PAX6 regulation and corneal inflammation.

Sci Rep

November 2024

Division of Ophthalmology, Department of Biomedical and Clinical Sciences, Linköping University, 581 83, Linköping, Sweden.

Article Synopsis
  • Congenital aniridia causes significant vision loss due to the absence of PAX6 protein, leading to related eye issues.
  • The study investigates the role of miR-204-5p in regulating PAX6 function, showing that while it effectively suppresses specific gene expressions in lab models, results vary in different cell types.
  • In animal models, topical treatment with miR-204-5p did not achieve expected outcomes regarding PAX6 levels or inflammatory gene suppression, indicating the need for more research on long-term effects.
View Article and Find Full Text PDF

Background: Small cell lung cancer (SCLC) stands as one of the most lethal malignancies, characterized by a grim diagnosis and prognosis. The emergence of multi-drug resistance poses a significant hurdle to effective therapy. Although previous studies have implicated the long noncoding RNA LYPLAL1-DT in the tumorigenesis of SCLC, the precise role of the highly expressed LYPLAL1-DT in SCLC chemoresistance and the underlying mechanism remain inadequately understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!